A detailed history of Pro Share Advisors LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,212 shares of PRTA stock, worth $181,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,212
Holding current value
$181,746
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.73 - $24.79 $187,576 - $277,945
11,212 New
11,212 $187,000
Q1 2024

May 08, 2024

BUY
$24.75 - $40.66 $23,067 - $37,895
932 Added 8.95%
11,346 $281,000
Q4 2023

Feb 14, 2024

BUY
$32.31 - $52.32 $49,305 - $79,840
1,526 Added 17.17%
10,414 $378,000
Q3 2023

Nov 13, 2023

BUY
$47.3 - $70.6 $3,878 - $5,789
82 Added 0.93%
8,888 $428,000
Q2 2023

Aug 10, 2023

BUY
$48.26 - $78.59 $26,832 - $43,696
556 Added 6.74%
8,806 $601,000
Q1 2023

May 25, 2023

BUY
$46.97 - $58.27 $387,502 - $480,727
8,250 New
8,250 $399,000
Q4 2022

Feb 02, 2023

BUY
$52.05 - $65.0 $44,815 - $55,965
861 Added 10.96%
8,719 $525,000
Q3 2022

Nov 04, 2022

BUY
$25.16 - $60.63 $5,736 - $13,823
228 Added 2.99%
7,858 $476,000
Q2 2022

Aug 01, 2022

SELL
$22.73 - $39.98 $90,442 - $159,080
-3,979 Reduced 34.28%
7,630 $207,000
Q1 2022

May 10, 2022

SELL
$30.27 - $49.22 $86,178 - $140,129
-2,847 Reduced 19.69%
11,609 $424,000
Q4 2021

Feb 08, 2022

BUY
$42.11 - $73.26 $14,949 - $26,007
355 Added 2.52%
14,456 $715,000
Q3 2021

Nov 12, 2021

SELL
$48.2 - $78.89 $129,368 - $211,740
-2,684 Reduced 15.99%
14,101 $1 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $57.65 $65,538 - $174,679
3,030 Added 22.03%
16,785 $863,000
Q1 2021

May 14, 2021

BUY
$11.0 - $28.24 $8,591 - $22,055
781 Added 6.02%
13,755 $346,000
Q4 2020

Feb 09, 2021

BUY
$10.12 - $13.94 $28,042 - $38,627
2,771 Added 27.16%
12,974 $156,000
Q3 2020

Nov 13, 2020

SELL
$9.93 - $13.47 $3,525 - $4,781
-355 Reduced 3.36%
10,203 $102,000
Q2 2020

Aug 03, 2020

BUY
$9.56 - $12.51 $100,934 - $132,080
10,558 New
10,558 $110,000
Q1 2020

May 15, 2020

SELL
$7.54 - $15.77 $106,140 - $221,994
-14,077 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$7.48 - $17.01 $9,724 - $22,113
-1,300 Reduced 8.45%
14,077 $223,000
Q3 2019

Nov 12, 2019

SELL
$6.89 - $10.45 $3,507 - $5,319
-509 Reduced 3.2%
15,377 $121,000
Q2 2019

Aug 13, 2019

SELL
$8.85 - $12.49 $17,903 - $25,267
-2,023 Reduced 11.3%
15,886 $168,000
Q1 2019

May 15, 2019

BUY
$10.32 - $14.49 $1,682 - $2,361
163 Added 0.92%
17,909 $217,000
Q4 2018

Feb 14, 2019

SELL
$8.73 - $13.74 $29,839 - $46,963
-3,418 Reduced 16.15%
17,746 $183,000
Q3 2018

Nov 14, 2018

SELL
$12.7 - $15.79 $10,985 - $13,658
-865 Reduced 3.93%
21,164 $277,000
Q2 2018

Aug 13, 2018

SELL
$10.99 - $44.21 $8,297 - $33,378
-755 Reduced 3.31%
22,029 $321,000
Q1 2018

May 14, 2018

SELL
$27.95 - $45.04 $101,486 - $163,540
-3,631 Reduced 13.75%
22,784 $836,000
Q4 2017

Feb 14, 2018

BUY
$35.44 - $63.76 $78,605 - $141,419
2,218 Added 9.17%
26,415 $990,000
Q3 2017

Nov 13, 2017

BUY
$53.83 - $67.75 $69,279 - $87,194
1,287 Added 5.62%
24,197 $1.57 Million
Q2 2017

Aug 11, 2017

BUY
N/A
22,910
22,910 $1.24 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $761M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.